F, F., Q, Z., L, M., A, W., Z, W., & X, X. (2026). Case Report: Dupilumab-associated ulcerative colitis: elucidating the pathomechanistic link between Th2 blockade and Th17 polarized intestinal inflammation. Frontiers in immunology, 17, 1875748. https://doi.org/10.3389/fimmu.2026.1875748
Chicago Style (17th ed.) CitationF, Fu, Zhao Q, Ma L, Wang A, Wang Z, and Xu X. "Case Report: Dupilumab-associated Ulcerative Colitis: Elucidating the Pathomechanistic Link Between Th2 Blockade and Th17 Polarized Intestinal Inflammation." Frontiers in Immunology 17 (2026): 1875748. https://doi.org/10.3389/fimmu.2026.1875748.
MLA (9th ed.) CitationF, Fu, et al. "Case Report: Dupilumab-associated Ulcerative Colitis: Elucidating the Pathomechanistic Link Between Th2 Blockade and Th17 Polarized Intestinal Inflammation." Frontiers in Immunology, vol. 17, 2026, p. 1875748, https://doi.org/10.3389/fimmu.2026.1875748.